aluates Reports

$ 0.0

Automative

Thrombin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-37O2970

Global Thrombin Market Insights and Forecast to 2026

BUY CHAPTERS

Thrombin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37O2970

Report

September 2024

Pages:124

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

CSL Limited

Grifols S A

GE Healthcare

Hualan Biological

Haematologic Technologies Inc.

Pfizer Inc

Octapharma AG

Omrix Biopharmaceuticals Ltd.

Shanghai Raas

Takeda

Thrombin - Market Size

The global market for Thrombin was estimated to be worth US$ 565 million in 2023 and is forecast to a readjusted size of US$ 704.7 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030

Thrombin - Market

Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.

North American market for Thrombin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Thrombin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Thrombin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Thrombin include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Thrombin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thrombin by region & country, by Type, and by Application.

The Thrombin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin.

Market Segmentation

Scope of Thrombin - Market Report

Report Metric	Details
Report Name	Thrombin - Market
Forecasted market size in 2030	US$ 704.7 million
CAGR	3.2%
Forecasted years	2024 - 2030
Segment by Type:	Powder Form Solution Form Pad Form Spray Kits Others
Segment by Application	Hospitals Diagnostics & Clinics Academic and Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer, Octapharma, Omrix Biopharmaceuticals Ltd., Shanghai RAAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Thrombin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Thrombin - Market size in 2030?

Ans: The Thrombin - Market size in 2030 will be US$ 704.7 million.

Who are the main players in the Thrombin - Market report?

Ans: The main players in the Thrombin - Market are Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer, Octapharma, Omrix Biopharmaceuticals Ltd., Shanghai RAAS

What are the Application segmentation covered in the Thrombin - Market report?

Ans: The Applications covered in the Thrombin - Market report are Hospitals, Diagnostics & Clinics, Academic and Research Institute

What are the Type segmentation covered in the Thrombin - Market report?

Ans: The Types covered in the Thrombin - Market report are Powder Form, Solution Form, Pad Form, Spray Kits, Others

Recommended Reports

Hemostasis Devices

Coagulation Analyzers

Thrombotic Treatments

1 Market Overview

1.1 Thrombin Product Introduction

1.2 Global Thrombin Market Size Forecast

1.2.1 Global Thrombin Sales Value (2019-2030)

1.2.2 Global Thrombin Sales Volume (2019-2030)

1.2.3 Global Thrombin Sales Price (2019-2030)

1.3 Thrombin Market Trends & Drivers

1.3.1 Thrombin Industry Trends

1.3.2 Thrombin Market Drivers & Opportunity

1.3.3 Thrombin Market Challenges

1.3.4 Thrombin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Thrombin Players Revenue Ranking (2023)

2.2 Global Thrombin Revenue by Company (2019-2024)

2.3 Global Thrombin Players Sales Volume Ranking (2023)

2.4 Global Thrombin Sales Volume by Company Players (2019-2024)

2.5 Global Thrombin Average Price by Company (2019-2024)

2.6 Key Manufacturers Thrombin Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Thrombin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Thrombin

2.9 Thrombin Market Competitive Analysis

2.9.1 Thrombin Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Thrombin Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Powder Form

3.1.2 Solution Form

3.1.3 Pad Form

3.1.4 Spray Kits

3.1.5 Others

3.2 Global Thrombin Sales Value by Type

3.2.1 Global Thrombin Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Thrombin Sales Value, by Type (2019-2030)

3.2.3 Global Thrombin Sales Value, by Type (%) (2019-2030)

3.3 Global Thrombin Sales Volume by Type

3.3.1 Global Thrombin Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Thrombin Sales Volume, by Type (2019-2030)

3.3.3 Global Thrombin Sales Volume, by Type (%) (2019-2030)

3.4 Global Thrombin Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Diagnostics & Clinics

4.1.3 Academic and Research Institute

4.2 Global Thrombin Sales Value by Application

4.2.1 Global Thrombin Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Thrombin Sales Value, by Application (2019-2030)

4.2.3 Global Thrombin Sales Value, by Application (%) (2019-2030)

4.3 Global Thrombin Sales Volume by Application

4.3.1 Global Thrombin Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Thrombin Sales Volume, by Application (2019-2030)

4.3.3 Global Thrombin Sales Volume, by Application (%) (2019-2030)

4.4 Global Thrombin Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Thrombin Sales Value by Region

5.1.1 Global Thrombin Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Thrombin Sales Value by Region (2019-2024)

5.1.3 Global Thrombin Sales Value by Region (2025-2030)

5.1.4 Global Thrombin Sales Value by Region (%), (2019-2030)

5.2 Global Thrombin Sales Volume by Region

5.2.1 Global Thrombin Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Thrombin Sales Volume by Region (2019-2024)

5.2.3 Global Thrombin Sales Volume by Region (2025-2030)

5.2.4 Global Thrombin Sales Volume by Region (%), (2019-2030)

5.3 Global Thrombin Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Thrombin Sales Value, 2019-2030

5.4.2 North America Thrombin Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Thrombin Sales Value, 2019-2030

5.5.2 Europe Thrombin Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Thrombin Sales Value, 2019-2030

5.6.2 Asia Pacific Thrombin Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Thrombin Sales Value, 2019-2030

5.7.2 South America Thrombin Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Thrombin Sales Value, 2019-2030

5.8.2 Middle East & Africa Thrombin Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Thrombin Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Thrombin Sales Value

6.2.1 Key Countries/Regions Thrombin Sales Value, 2019-2030

6.2.2 Key Countries/Regions Thrombin Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Thrombin Sales Value, 2019-2030

6.3.2 United States Thrombin Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Thrombin Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Thrombin Sales Value, 2019-2030

6.4.2 Europe Thrombin Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Thrombin Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Thrombin Sales Value, 2019-2030

6.5.2 China Thrombin Sales Value by Type (%), 2023 VS 2030

6.5.3 China Thrombin Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Thrombin Sales Value, 2019-2030

6.6.2 Japan Thrombin Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Thrombin Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Thrombin Sales Value, 2019-2030

6.7.2 South Korea Thrombin Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Thrombin Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Thrombin Sales Value, 2019-2030

6.8.2 Southeast Asia Thrombin Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Thrombin Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Thrombin Sales Value, 2019-2030

6.9.2 India Thrombin Sales Value by Type (%), 2023 VS 2030

6.9.3 India Thrombin Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Thrombin Product Offerings

7.1.5 Takeda Recent Development

7.2 Bayer

7.2.1 Bayer Company Information

7.2.2 Bayer Introduction and Business Overview

7.2.3 Bayer Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer Thrombin Product Offerings

7.2.5 Bayer Recent Development

7.3 CSL

7.3.1 CSL Company Information

7.3.2 CSL Introduction and Business Overview

7.3.3 CSL Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CSL Thrombin Product Offerings

7.3.5 CSL Recent Development

7.4 Grifols

7.4.1 Grifols Company Information

7.4.2 Grifols Introduction and Business Overview

7.4.3 Grifols Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Grifols Thrombin Product Offerings

7.4.5 Grifols Recent Development

7.5 GE Healthcare

7.5.1 GE Healthcare Company Information

7.5.2 GE Healthcare Introduction and Business Overview

7.5.3 GE Healthcare Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.5.4 GE Healthcare Thrombin Product Offerings

7.5.5 GE Healthcare Recent Development

7.6 Hualan Biological

7.6.1 Hualan Biological Company Information

7.6.2 Hualan Biological Introduction and Business Overview

7.6.3 Hualan Biological Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Hualan Biological Thrombin Product Offerings

7.6.5 Hualan Biological Recent Development

7.7 Haematologic Technologies Inc.

7.7.1 Haematologic Technologies Inc. Company Information

7.7.2 Haematologic Technologies Inc. Introduction and Business Overview

7.7.3 Haematologic Technologies Inc. Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Haematologic Technologies Inc. Thrombin Product Offerings

7.7.5 Haematologic Technologies Inc. Recent Development

7.8 Pfizer

7.8.1 Pfizer Company Information

7.8.2 Pfizer Introduction and Business Overview

7.8.3 Pfizer Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Pfizer Thrombin Product Offerings

7.8.5 Pfizer Recent Development

7.9 Octapharma

7.9.1 Octapharma Company Information

7.9.2 Octapharma Introduction and Business Overview

7.9.3 Octapharma Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Octapharma Thrombin Product Offerings

7.9.5 Octapharma Recent Development

7.10 Omrix Biopharmaceuticals Ltd.

7.10.1 Omrix Biopharmaceuticals Ltd. Company Information

7.10.2 Omrix Biopharmaceuticals Ltd. Introduction and Business Overview

7.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Product Offerings

7.10.5 Omrix Biopharmaceuticals Ltd. Recent Development

7.11 Shanghai RAAS

7.11.1 Shanghai RAAS Company Information

7.11.2 Shanghai RAAS Introduction and Business Overview

7.11.3 Shanghai RAAS Thrombin Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Shanghai RAAS Thrombin Product Offerings

7.11.5 Shanghai RAAS Recent Development

8 Industry Chain Analysis

8.1 Thrombin Industrial Chain

8.2 Thrombin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Thrombin Sales Model

8.5.2 Sales Channel

8.5.3 Thrombin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bayer

CSL Limited

Grifols S A

GE Healthcare

Hualan Biological

Haematologic Technologies Inc.

Pfizer Inc

Octapharma AG

Omrix Biopharmaceuticals Ltd.

Shanghai Raas

Takeda

List of Tables

Table 1. Thrombin Market Trends

Table 2. Thrombin Market Drivers & Opportunity

Table 3. Thrombin Market Challenges

Table 4. Thrombin Market Restraints

Table 5. Global Thrombin Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Thrombin Revenue Market Share by Company (2019-2024)

Table 7. Global Thrombin Sales Volume by Company (2019-2024) & (MT)

Table 8. Global Thrombin Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Thrombin Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Thrombin Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Thrombin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Thrombin

Table 13. Global Thrombin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Thrombin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Thrombin Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Thrombin Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Thrombin Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Thrombin Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Thrombin Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)

Table 22. Global Thrombin Sales Volume by Type (2019-2024) & (MT)

Table 23. Global Thrombin Sales Volume by Type (2025-2030) & (MT)

Table 24. Global Thrombin Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Thrombin Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Thrombin Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Thrombin Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Thrombin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Thrombin Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Thrombin Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Thrombin Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Thrombin Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Thrombin Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)

Table 34. Global Thrombin Sales Volume by Application (2019-2024) & (MT)

Table 35. Global Thrombin Sales Volume by Application (2025-2030) & (MT)

Table 36. Global Thrombin Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Thrombin Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Thrombin Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Thrombin Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Thrombin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Thrombin Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Thrombin Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Thrombin Sales Value by Region (2019-2024) & (%)

Table 44. Global Thrombin Sales Value by Region (2025-2030) & (%)

Table 45. Global Thrombin Sales Volume by Region (MT): 2019 VS 2023 VS 2030

Table 46. Global Thrombin Sales Volume by Region (2019-2024) & (MT)

Table 47. Global Thrombin Sales Volume by Region (2025-2030) & (MT)

Table 48. Global Thrombin Sales Volume by Region (2019-2024) & (%)

Table 49. Global Thrombin Sales Volume by Region (2025-2030) & (%)

Table 50. Global Thrombin Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Thrombin Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Thrombin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Thrombin Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Thrombin Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Thrombin Sales Volume, (2019-2024) & (MT)

Table 56. Key Countries/Regions Thrombin Sales Volume, (2025-2030) & (MT)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. Takeda Thrombin Product Offerings

Table 61. Takeda Recent Development

Table 62. Bayer Company Information

Table 63. Bayer Introduction and Business Overview

Table 64. Bayer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. Bayer Thrombin Product Offerings

Table 66. Bayer Recent Development

Table 67. CSL Company Information

Table 68. CSL Introduction and Business Overview

Table 69. CSL Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. CSL Thrombin Product Offerings

Table 71. CSL Recent Development

Table 72. Grifols Company Information

Table 73. Grifols Introduction and Business Overview

Table 74. Grifols Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. Grifols Thrombin Product Offerings

Table 76. Grifols Recent Development

Table 77. GE Healthcare Company Information

Table 78. GE Healthcare Introduction and Business Overview

Table 79. GE Healthcare Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 80. GE Healthcare Thrombin Product Offerings

Table 81. GE Healthcare Recent Development

Table 82. Hualan Biological Company Information

Table 83. Hualan Biological Introduction and Business Overview

Table 84. Hualan Biological Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 85. Hualan Biological Thrombin Product Offerings

Table 86. Hualan Biological Recent Development

Table 87. Haematologic Technologies Inc. Company Information

Table 88. Haematologic Technologies Inc. Introduction and Business Overview

Table 89. Haematologic Technologies Inc. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 90. Haematologic Technologies Inc. Thrombin Product Offerings

Table 91. Haematologic Technologies Inc. Recent Development

Table 92. Pfizer Company Information

Table 93. Pfizer Introduction and Business Overview

Table 94. Pfizer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 95. Pfizer Thrombin Product Offerings

Table 96. Pfizer Recent Development

Table 97. Octapharma Company Information

Table 98. Octapharma Introduction and Business Overview

Table 99. Octapharma Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 100. Octapharma Thrombin Product Offerings

Table 101. Octapharma Recent Development

Table 102. Omrix Biopharmaceuticals Ltd. Company Information

Table 103. Omrix Biopharmaceuticals Ltd. Introduction and Business Overview

Table 104. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 105. Omrix Biopharmaceuticals Ltd. Thrombin Product Offerings

Table 106. Omrix Biopharmaceuticals Ltd. Recent Development

Table 107. Shanghai RAAS Company Information

Table 108. Shanghai RAAS Introduction and Business Overview

Table 109. Shanghai RAAS Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. Shanghai RAAS Thrombin Product Offerings

Table 111. Shanghai RAAS Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Thrombin Downstream Customers

Table 115. Thrombin Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Thrombin Product Picture

Figure 2. Global Thrombin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Thrombin Sales Volume (2019-2030) & (MT)

Figure 5. Global Thrombin Sales Price (2019-2030) & (USD/Kg)

Figure 6. Thrombin Report Years Considered

Figure 7. Global Thrombin Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Thrombin Players Sales Volume Ranking (2023) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Thrombin Revenue in 2023

Figure 10. Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Powder Form Picture

Figure 12. Solution Form Picture

Figure 13. Pad Form Picture

Figure 14. Spray Kits Picture

Figure 15. Others Picture

Figure 16. Global Thrombin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Thrombin Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Thrombin Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)

Figure 19. Global Thrombin Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Thrombin Price by Type (2019-2030) & (USD/Kg)

Figure 21. Product Picture of Hospitals

Figure 22. Product Picture of Diagnostics & Clinics

Figure 23. Product Picture of Academic and Research Institute

Figure 24. Global Thrombin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Thrombin Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Thrombin Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)

Figure 27. Global Thrombin Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Thrombin Price by Application (2019-2030) & (USD/Kg)

Figure 29. North America Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Thrombin Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Thrombin Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Thrombin Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Thrombin Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Thrombin Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Thrombin Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Thrombin Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Thrombin Sales Volume (%), (2019-2030)

Figure 41. United States Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 47. China Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 49. China Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 59. India Thrombin Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Thrombin Sales Value by Type (%), 2023 VS 2030

Figure 61. India Thrombin Sales Value by Application (%), 2023 VS 2030

Figure 62. Thrombin Industrial Chain

Figure 63. Thrombin Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Human Thrombin Protein Market Research Report 2024

Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antithrombin Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Coagulation Factor VII Market Insights Forecast to 2030

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Topical Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024

Global Thrombin Inhibitor Market Research Report 2024

Global Topical Recombinant Thrombin Market Research Report 2024

Global Topical Recombinant Human Thrombin Market Research Report 2024

Coagulation Factor IX Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Factor Xa Market Research Report 2025

Global Anti thrombin III Testing Market Insights Forecast to 2030

Global Management of Antithrombin Market Research Report 2024

Global Thrombin Human Market Research Report 2025

Global Thrombin Preparation Market Research Report 2024

Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions